Cell BioEngines
Off-the-shelf curative cell therapies for all patients
New York, United States · Founded 2022
- Headquarters
- New York, New York
- Employees
- 1–10
- Founded
- 2022
- Business Model
- B2B
- Website
- cellbioengines.com
- Last Round
- SeedJul 2024
- Rounds
- 2
About
Cell BioEngines is a clinical-stage biotechnology company pioneering off-the-shelf, allogeneic cell therapies for oncology and regenerative medicine. Founded in December 2022, the company's proprietary STEM-Space™ platform enables transgene-free chemical reprogramming of stem cells without genetic engineering, combined with HLA-guided design and a population-informed biobank to achieve broad patient coverage. Unlike autologous therapies that require patient-specific manufacturing, Cell BioEngines' approach enables scalable, low-cost production of standardized cell-based therapeutics that can be stockpiled and distributed like conventional drugs.
Summary
Cell BioEngines is a company based in New York, United States, founded in 2022. Its most recent funding was a Seed round in Jul 2024. Investors include SOSV and IndieBio.
Tech & App Stack
1 technologies & apps tracked
Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jul 2024
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
